Press Releases Agios Pharmaceuticals, Inc.

Equities

AGIO

US00847X1046

Real-time Estimate Cboe BZX Other stock markets 02:50:15 2024-05-24 pm EDT			5-day change	1st Jan Change
31.86 ^USD	-2.52%		-6.96%	+43.47%

May. 16	Transcript : Agios Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:40 AM
May. 02	Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress	May. 14	AQ
Agios Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024	May. 06	AQ
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024	May. 06	AQ
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024	May. 03	AQ
Agios Pharmaceuticals : First Quarter 2024 Financial Results Presentation	May. 02	PU
Agios Pharmaceuticals: Q1 Earnings Snapshot	May. 02	AQ
Agios Reports Business Highlights and First Quarter 2024 Financial Results	May. 02	AQ
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	Apr. 18	AQ
Agios Publishes 2024 Environmental, Social and Governance Report	Apr. 10	AQ
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	Apr. 09	AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	Mar. 06	AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	Mar. 05	AQ
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	Feb. 22	AQ
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	Feb. 15	AQ
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024	Feb. 02	AQ
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio	Jan. 08	AQ
Agios Pharmaceuticals : ENERGIZE Phase 3 Topline Results	Jan. 03	PU
Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia	Jan. 03	AQ
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024	Jan. 02	AQ
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition	Dec. 09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Agios Pharmaceuticals, Inc.

Equities

AGIO

US00847X1046

Press Releases

Filters